ORGANO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,810 JPY | +4.14% |
|
+5.13% | +50.86% |
| Sales 2024 | 150B 955M | Sales 2025 * | 157B 999M | Capitalization | 405B 2.57B |
|---|---|---|---|---|---|
| Net income 2024 | 17.31B 110M | Net income 2025 * | 17.17B 109M | EV / Sales 2024 | 2.35 x |
| Net Debt 2024 * | 9.93B 63.09M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.57 x |
| P/E ratio 2024 |
20.4
x | P/E ratio 2025 * |
23.6
x | Employees | 2,506 |
| Yield 2024 |
1.32% | Yield 2025 * |
1.18% | Free-Float | 53.69% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +4.14% | ||
| 1 week | +5.13% | ||
| 1 month | +19.86% | ||
| 3 months | +14.86% | ||
| 6 months | +45.38% | ||
| Current year | +50.86% |
1 week
8 240.00
8 860.00
1 month
7 400.008 860.00
Current year
5 520.008 860.00
1 year
3 625.008 860.00
3 years
1 457.508 860.00
5 years
776.258 860.00
10 years
471.258 860.00
| Managers | Title | Age | Since |
|---|---|---|---|
Masayuki Yamada
PSD | President | 65 | 19-05-31 |
Masaki Uchikura
CHM | Chairman | 69 | 17-06-28 |
Nobuyoshi Suda
CTO | Chief Tech/Sci/R&D Officer | 60 | 84-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Motoo Nagai
BRD | Director/Board Member | 70 | 14-05-31 |
Masaki Uchikura
CHM | Chairman | 69 | 17-06-28 |
Masahiko Toyoda
AUD | Comptroller/Controller/Auditor | 68 | 12-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.99% | 4 M€ | +10.40% | - | |
| 0.28% | 10 M€ | +23.42% | ||
| 0.02% | 140,441 M€ | +19.22% | ||
| 0.02% | 63,295 M€ | +18.52% | - | |
| 0.02% | 20,360 M€ | +16.70% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 8,810 | +4.14% | 345,700 |
| 24-05-30 | 8,460 | -.--% | 236,300 |
| 24-05-29 | 8,460 | -1.86% | 269,500 |
| 24-05-28 | 8,620 | -0.46% | 269,200 |
| 24-05-27 | 8,660 | +3.34% | 350,700 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
ORGANO CORPORATION is a Japan-based company mainly engaged in the water treatment engineering business and functional products business. The Company operates through two business segments. The Water Treatment Engineering segment is mainly engaged in the manufacture, sale, maintenance and management of filtration equipment, pure water system equipment and other water treatment related equipment. The Functional Product segment is mainly engaged in the manufacture and sale of standard water treatment equipment, water treatment chemicals and food additives. The Company is also engaged in the chemical plant construction business.
Calendar
2024-07-30
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8,810
JPY
Average target price
8,000
JPY
Spread / Average Target
-9.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +50.86% | 2.57B | |
| +12.75% | 8.87B | |
| -14.86% | 1.01B | |
| +23.42% | 874M | |
| +24.67% | 721M | |
| -8.95% | 754M | |
| +16.43% | 696M | |
| -17.24% | 583M | |
| -11.94% | 533M | |
| +5.98% | 527M |
- Stock Market
- Equities
- 6368 Stock
